Print

FDA Approves Allergan Inc. (AGN)'s JUVÉDERM VOLUMA™ XC  
10/23/2013 10:13:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the first and only filler approved to temporarily correct age-related volume loss in the cheek area in adults over the age of 21. JUVÉDERM VOLUMA™ XC helps create a more youthful appearance to the face and provides natural-looking and long-lasting results up to two years with optimal treatment.1

Help employers find you! Check out all the jobs and post your resume.

//-->